Crwe Surpasses One Million In Sales For 2010, Stock Update On Wcrx, And Dtpi Merger
Crown Equity Holdings Inc
Crown Equity Holdings Inc. (OTCBB:CRWE)
CRWE release news that its sales this year have already surpassed $1,000,000.
This compares to $232,510 for the three quarters ending September 30, 2009 and $ 659,907 total sales for the year 2009.
Kenneth Bosket, President and CEO of Crown Equity Holdings Inc. commented "Based on our sales to date, we had more than 4 times the sales for the same period last year and are 34% ahead of last year's total sales."
Mr. Bosket also stated "Our growth in sales along with our investments in infrastructure and people give the company a basis for supporting future growth of the magnitude we have seen so far this year."
CRWE has also moved to a dedicated in-house advertising server, allowing for faster response and a wider variety of ad space offerings to those interested in advertising on their numerous internet and affiliate internet properties.
CRWE is currently in the process of expanding its in-house IT infrastructure. Although their current web page load time is better than 75% of other internet websites, when completed, the modifications will raise this load time to better then 90% of other internet websites while increasing website visitor capacity by 400%.
CRWE has expanded its internet footprint internationally to include the following 19 countries: Argentina, Australia, Brazil, Canada, China, France, Germany, Hong Kong, India, Ireland, Italy, Japan, Korea, Mexico, New Zealand, Singapore, Spain, Taiwan and the UK.
PricewaterhouseCoopers LLP and Diamond Management & Technology Consultants, Inc. (Nasdaq:DTPI), a strategic management consulting firm, has announced that they have entered into a definitive merger agreement whereby PricewaterhouseCoopers LLP will acquire all of the outstanding common shares of DTPI for $12.50 per share in cash. The transaction represents a premium of 31% to DTPI's closing stock price of $9.54 on August 23, 2010, and values DTPI at $378 million. DTPI will join the PwC Advisory practice, which ranks among the largest providers of consulting services globally.
DTPI provides strategic management consulting services to help companies grow, improve margins, and increase the productivity of their investments. DTPI's consultants are experienced in helping clients attract and retain customers, increase the value of their information, and plan and execute projects that turn strategy into measurable results. DTPI employs more than 500 consultants worldwide and has offices in Chicago, Hartford, New York, Washington D.C., London, and Mumbai.
The transaction, which has been unanimously approved by both companies' boards, is expected to close in the fourth quarter of calendar year 2010, subject to customary closing conditions, including the approval of DTPI's stockholders and antitrust clearance.
Warner Chilcott plc (Nasdaq:WCRX) recently announced that it has received the Food and Drug Administration's ("FDA's") response to a citizen petition it had filed regarding its ASACOL and ASACOL HD products. In its petition, WCRX requested that the FDA (1) issue bioequivalence guidance for mesalamine delayed-release tablets, (2) not approve any abbreviated new drug applications ("ANDAs") referencing ASACOL and/or ASACOL HD unless the proposed generic product is shown to be bioequivalent based on appropriate data from a clinical efficacy endpoint study, comparative pharmacokinetic testing and rigorous in vitro dissolution testing and (3) deny any waiver of bioequivalence testing for either ASACOL or ASACOL HD based on a showing of bioequivalence in the other strength. In its joint-response to the citizen petitions of the Company and another petitioner, the FDA has granted in part and denied in part various aspects of the citizen petitions. The impact of the FDA's response will depend upon the particular facts of any ANDA filed referencing ASACOL and/or ASACOL HD. A copy of the FDA's response letter is available in the Investor Relations section of the Company's website at www.wcrx.com.
For FREE Daily Stock Alerts & Updates Signup At: http://pennytobuck.com/signup
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PennyToBuck.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers.Our disclaimer ( http://pennytobuck.com/disclaimer) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold PennyToBuck.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations.The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.
by: Bill Pennyman
Maruti's total sales stood at 104,791 units in Aug 2010 Toyota registers 26% sales growth in Aug 2010 Using Spending Incentives For Increasing Sales Sales Through Check Moves Top Estimates Of Dell Sales Achivement Understanding Short Sales: Are They A Viable Foreclosure Alternative? Get More Sales With The Right Links What Is Reseller Hosting? Reviving Dismal App Sales Making Sales Via Facebook Five Ways To Have Sizzling Summer Sales The South Is Beautiful This Season Get Tips On How To Book The Greatest Sales On Grand Strand Vacati Myrtle Beach Is Breathtaking Any Time Of Year Get Information On How To Search Out Low-cost Sales On
Crwe Surpasses One Million In Sales For 2010, Stock Update On Wcrx, And Dtpi Merger Anaheim